Daniel Barber, President and CEO: Aquestive Therapeutics AQST Planned sale · Filed 25/09/19

Trade details

Type: Planned sale notice
Stock: Aquestive Therapeutics AQST
Person: Daniel BarberPresident and CEO
Planned sale date: 25/09/19
Filed: 25/09/19

$1,976 to be sold

Aquestive Therapeutics trades, last 26 weeks

What else happened in Aquestive Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/20~25/10/19

Daniel Barber's recent trades

Daniel BarberPresident and CEO
Planned sale10b5-1 planAquestive Therapeutics
Planned sale10b5-1 plan
Aquestive Therapeutics
AQST
$244K
50,000 sh
$244K
Filed 09/15
Traded 09/15
Daniel BarberPresident and CEO
Planned sale10b5-1 planAquestive Therapeutics
Planned sale10b5-1 plan
Aquestive Therapeutics
AQST
$106.3K
25,000 sh
$106.3K
Filed 08/17
Traded 08/17
Daniel BarberPresident and CEO
Planned sale10b5-1 planAquestive Therapeutics
Planned sale10b5-1 plan
Aquestive Therapeutics
AQST
$101K
25,000 sh
$101K
Filed 07/15
Traded 07/15
Daniel BarberPresident and CEO
Sell10b5-1 planAquestive Therapeutics
Sell10b5-1 plan
Aquestive Therapeutics
AQST
$104K
25,000 sh
$104K
Filed 06/16
Traded 06/15
Daniel BarberPresident and CEO
Planned sale10b5-1 planAquestive Therapeutics
Planned sale10b5-1 plan
Aquestive Therapeutics
AQST
$104.3K
25,000 sh
$104.3K
Filed 06/15
Traded 06/15

Daniel Barber, CEO — plans to sell 400 sh of Aquestive Therapeutics AQST · $1,976 · around 09/19 · 10b5-1 plan | Whalegun